Publications by authors named "R Bhalerao"

This paper introduces the Automated Lesion and Feature Extraction (ALFE) pipeline, an open-source, Python-based pipeline that consumes MR images of the brain and produces anatomical segmentations, lesion segmentations, and human-interpretable imaging features describing the lesions in the brain. ALFE pipeline is modeled after the neuroradiology workflow and generates features that can be used by physicians for quantitative analysis of clinical brain MRIs and for machine learning applications. The pipeline uses a decoupled design which allows the user to customize the image processing, image registrations, and AI segmentation tools without the need to change the business logic of the pipeline.

View Article and Find Full Text PDF

Noise is a ubiquitous feature for all organisms growing in nature. Noise (defined here as stochastic variation) in the availability of nutrients, water and light profoundly impacts their growth and development. Not only is noise present as an external factor but cellular processes themselves are noisy.

View Article and Find Full Text PDF

Objective:  The study was undertaken to evaluate the protective effect of (EP) 30C on the incidence of dengue fever.

Design:  This study was designed as a prospective, open label, parallel cohort study.

Interventions:  Participants were enrolled in two medicine cohort (MC) communities and one control cohort (CC) community.

View Article and Find Full Text PDF

The trans-Golgi network (TGN), a key compartment in endomembrane trafficking, participates in both secretion to and endocytosis from the plasma membrane. Consequently, the TGN plays a key role in plant growth and development. Understanding how proteins are sorted for secretion or endocytic recycling at the TGN is critical for elucidating mechanisms of plant development.

View Article and Find Full Text PDF
Article Synopsis
  • Fibrous dysplasia (FD) is a non-cancerous bone condition that can cause bone pain, deformities, and fractures, particularly affecting the cranio-facial region.
  • A study at a surgical oncology department followed seven patients with cranio-facial FD over 18.75 months, focusing on the effects of zolendronic acid, a medication used for bone conditions.
  • Results showed significant improvements in patients' pain levels and other clinical markers, supporting the use of zolendronic acid as an effective treatment option for cranio-facial fibrous dysplasia.
View Article and Find Full Text PDF